pm mfvt1
    • Main page
      • About journal
      • Articles. Working with contents
      • Editor-in-chief
      • Editorial Council
      • Editorial Board


      • For authors
      • Standards for formatting information
      • Reviewing
      • Politics editorial board
      • Ethics of journal publications


      • For advertisers
      • Subscription
      • About the Publishing House
      • Contact us
  • Tag › aflibercept

    Anti-VEGF therapy in a specialized budgetary institution (by the data of Penza Regional Eye Hospital)

    Редактор | 2018, Practical medicine 03 (18) Ophthalmology, Офтальмология | 10 апреля, 2018

    S.L. KUZNETSOV1, R.S. GALEYEV2, F.A. ANESYAN3, E.E. BRAZHALOVICH1, K.A. VYAZOVKINA3, D.D. MAKAROVA3 1Penza Institute for Advanced Medical Education ― Branch Campus of the FSBEI FPE RMACPE MOH Russia, 8a Stasov Str., Penza, Russian Federation, 440062 2Penza Regional Eye Hospital, 32 Krasnaya Str., Penza, Russian Federation, 440026 3Medical Institute of Penza State University, 40 Krasnaya Str., […]

    Tag: 2018, aflibercept, anti-VEGF therapy, D.D. MAKAROVA, E.E. BRAZHALOVICH, F.A. ANESYAN, injection index, K.A. VYAZOVKINA, Practical medicine 03 (18) Ophthalmology, R.S. GALEYEV, ranibizumab, S.L. KUZNETSOV
    Комментарии к записи Anti-VEGF therapy in a specialized budgetary institution (by the data of Penza Regional Eye Hospital) отключены

    Immediate results of switching the anti-VEGF agent in the treatment of neovascular age-related macular degeneration in clinical practice

    Редактор | 2017, Original articles, Practical medicine 03 (17) Ophthalmology | 27 апреля, 2017

    E.V. BOBYKIN, S.A. KOROTKIKH Ural State Medical University, 3 Repin Str., Yekaterinburg, Russian Federation, 620028  Bobykin E.V. ― Cand. Med. Sc., Associate Professor of the Department of Ophthalmology, tel. +7-912-240-03-63, e-mail: oculist.ev@gmail.com Korotkikh S.A. ― D. Med. Sc., Professor, Head of the Department of Ophthalmology, tel. (343) 214-86-67, e-mail: med@usma.ru Early results of the switching […]

    Tag: 03, 2017, aflibercept, E.V. BOBYKIN, neovascular («wet») age-related macular degeneration, ranibizumab, S.A. KOROTKIKH, switching
    Комментарии к записи Immediate results of switching the anti-VEGF agent in the treatment of neovascular age-related macular degeneration in clinical practice отключены
    • rus Версия на русском языке


      usa English version site


      Find loupe

      

    • PARTNERS

      пов  logonew
    «Для
    Practical medicine. Scientific and practical reviewed medical journal
    All rights reserved ©